Objective: Diffuse pulmonary opacities are seen in both pulmonary edema (PE) and pulmonary infections such as viral pneumonia (VP) and Pneumocystis jirovecii pneumonia (PJP), and distinguishing these from each other might be challenging. We aimed to show whether subcutaneous fat tissue density (SFTD) measurement in computed tomography scans helps to distinguish PE from VP and PJP. Material and Methods: In this retrospective study, SFTD, defined in terms of Hounsfield unit (HU) was evaluated in computed tomography scans of 99 patients with PE, 103 patients with VP and PJP, and 110 healthy individuals. The SFTD was calculated by using a region of interest with a diameter of approximately 1 cm in the subcutaneous adipose tissue, located 3 cm superior-inferior and medial-lateral to the junction of the midclavicular line and the xiphoid tip on the chest wall, blinded to the clinical data. Results: Median SFTD was -82.5 HU [interquartile range (IQR) -88.7; -67.4] in patients with PE, -117.7 HU (IQR - 121.3; -111.8) in patients with VP and PJP, and -120.3 HU (IQR -123.1; -117.0) in the control group (p<0.001). All patients with PE had SFTD at least -95 HU. None of the patients with VP and PJP as well as controls had SFTD less more -101 HU. Conclusion: Our results suggest that a SFTD measurement above -95 HU might be useful in differentiating PE from VP and PJP pneumonia in patients with diffuse lung opacities.
Keywords: Subcutaneous fat tissue density; pulmonary edema; pulmonary infection; chest CT
Amaç: Diffüz pulmoner opasiteler, hem pulmoner ödem (PÖ) hem de viral pnömoniler (VP) ile Pneumocystis jirovecii pnömonisi (PJP) gibi pulmoner enfeksiyonlarda görülür ve bu durumların birbirinden ayırt edilmesi zor olabilir. Bu çalışmada, toraks bilgisayarlı tomografi görüntülerinde yaygın akciğer opasiteleri olan hastalarda subkütan yağ dokusu dansitesini (SYDD) ölçerek, PÖ'yü, VP ve PJP'lerden ayırt etmeyi amaçladık. Gereç ve Yöntemler: Retrospektif olarak gerçekleştirilen bu çalışmada SYDD, Hounsfield birimi [Hounsfield unit (HU)] cinsinden tanımlandı; PÖ'lü 99 hasta, VP ve PJP'li 103 hasta ile 110 sağlıklı bireyin bilgisayarlı tomografi görüntüleri incelendi. SYDD ölçümleri, klinik bilgiler bilinmeden, midklavikular çizgi ile ksifoid çıkıntının birleşim noktasından 3 cm superior-inferior ve mediyal-lateral olarak göğüs duvarındaki subkütan yağ dokusunda, yaklaşık 1 cm çapında bir ilgi alanı kullanılarak hesaplandı. Bulgular: Medyan SYDD, PÖ hastalarında -82,5 HU [güven aralığı (GA) -88,7; -67,4], VP ve PJP hastalarında -117,7 HU (GA -121,3; -111,8), kontrol grubunda ise -120,3 HU (GA - 123,1; -117,0) olarak bulundu (p<0,001). PÖ hastalarının tamamında, SYDD en az -95 HU idi. Pnömoni hastalarında ve kontrol grubunda ise SYDD hiçbir hastada -101 HU'dan büyük değildi. Sonuç: Sonuçlarımız, yaygın akciğer opasitesi olan hastalarda -95 HU'dan büyük SYDD değerlerinin, PÖ'yü VP ile PJP'den ayırt etmede faydalı bir gösterge olabileceğini düşündürmektedir.
Anahtar Kelimeler: Subkütan yağ dokusu dansitesi; pulmoner ödem; pulmoner enfeksiyon; toraks BT
- Matos MJ, Rosa ME, Brito VM, Amaral LT, Beraldo GL, Fonseca EK, et al. Differential diagnoses of acute ground-glass opacity in chest computed tomography: pictorial essay. einstein (São Paulo). 2021;19:eRW5772. [Link]
- Ebadi M, Dunichand-Hoedl AR, Rider E, Kneteman NM, Shapiro J, Bigam D, et al. Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis. JHEP Rep. 2022;4(7):100495. [Crossref] [PubMed] [PMC]
- Hanley C, Shields KJ, Matthews KA, Brooks MM, Janssen I, Budoff MJ, et al. Associations of cardiovascular fat radiodensity and vascular calcification in midlife women: The SWAN cardiovascular fat ancillary study. Atherosclerosis. 2018;279:114-21. [PubMed] [PMC]
- Gifford A, Walker RC, Towse TF, Brian Welch E. Correlations between quantitative fat-water magnetic resonance imaging and computed tomography in human subcutaneous white adipose tissue. J Med Imaging (Bellingham). 2015;2(4):046001. [Crossref] [PubMed] [PMC]
- Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 2000;43(12):1498-506. [PubMed]
- Baba S, Jacene HA, Engles JM, Honda H, Wahl RL. CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med. 2010;51(2):246-50. [Crossref] [PubMed]
- Barile M. Pulmonary edema: a pictorial review of imaging manifestations and current understanding of mechanisms of disease. Eur J Radiol Open. 2020;7:100274. [PubMed] [PMC]
- Mensah S, Keung J, Svajlenko J, Ebo Bennin K, Mi Q. On the value of a prioritization scheme for resolving self-admitted technical debt. Journal of Systems and Software. 2018;135:37-54. [Crossref] [PubMed]
- Merckx J, Wali R, Schiller I, Caya C, Gore GC, Chartrand C, et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis. Ann Intern Med. 2017;167(6):394-409. [Crossref] [PubMed]
- Vos LM, Bruning AHL, Reitsma JB, Schuurman R, Riezebos-Brilman A, Hoepelman AIM, et al. Rapid molecular tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review of diagnostic accuracy and clinical impact studies. Clin Infect Dis. 2019;69(7):1243-53. [Crossref] [PubMed] [PMC]
- Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2023;613(7942):130-7. [Crossref] [PubMed] [PMC]
- Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavaldà J, Moreno A, et al; TRANSGRIPE 1?2 Study Group. Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial. Clin Infect Dis. 2017;64(7):829-38. [Crossref] [PubMed]
- Lagrou K, Chen S, Masur H, Viscoli C, Decker CF, Pagano L, et al. Pneumocystis jirovecii disease: basis for the revised EORTC/MSGERC invasive fungal disease definitions in individuals without human immunodeficiency virus. Clin Infect Dis. 2021;72(Suppl 2):S114-20. [Crossref] [PubMed] [PMC]
- Cozzi D, Cavigli E, Moroni C, Smorchkova O, Zantonelli G, Pradella S, et al. Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn J Radiol. 2021;39(8):721-32. [Crossref] [PubMed] [PMC]
- Marco-Martínez J, Elola-Somoza FJ, Fernández-Pérez C, Bernal-Sobrino JL, Azaña-Gómez FJ, García-Klepizg JL, et al. Heart failure is a poor prognosis risk factor in patients undergoing cholecystectomy: results from a spanish data-based analysis. J Clin Med. 2021;10(8):1731. [Crossref] [PubMed] [PMC]
- Blanco-Barrio A, Moreno-Pastor A, Lozano-Ros M. Fractures of the limbs: basic concepts for the emergency department. Radiología. 2023;65(Suppl 1):S42-52. [Crossref] [PubMed]
.: Process List